{"id":203947,"name":"PTC THERAPEUTICS","slug":"ptc-therapeutics","state":"NJ","country":"United States of America","description":"Biopharmaceutical","totalSpending":1250000,"filings":26,"yearlySpending":[{"year":2019,"income":50000},{"year":2020,"income":200000},{"year":2021,"income":200000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":200000}],"issues":["HCR"],"firms":["BGR GOVERNMENT AFFAIRS"],"lobbyists":["BRENT DEL MONTE","JOHN STONE","REMY MASON","ROBB WALTON","MATT HOFFMANN","DANIEL FARMER","JOEL BAILEY","RYAN LONG"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Centers For Medicare and Medicaid Services (CMS)"],"sampleDescriptions":["Drug development, review and pricing related issues.","Drug development, review and pricing related issues.","Drug development, review and pricing related issues.","Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and PTC Therapeutics specifically.","Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and PTC Therapeutics specifically."],"years":[2019,2020,2021,2022,2023,2024,2025]}